Last reviewed · How we verify
Depo-Provera Contraceptive Injection - DP150CI
Depo-Provera Contraceptive Injection - DP150CI is a Progestin contraceptive Small molecule drug developed by Pfizer. It is currently FDA-approved for Contraception in women of reproductive age.
Depo-Provera is a progestin injection that prevents pregnancy by suppressing ovulation and thickening cervical mucus.
Depo-Provera is a progestin injection that prevents pregnancy by suppressing ovulation and thickening cervical mucus. Used for Contraception in women of reproductive age.
At a glance
| Generic name | Depo-Provera Contraceptive Injection - DP150CI |
|---|---|
| Sponsor | Pfizer |
| Drug class | Progestin contraceptive |
| Target | Progesterone receptor |
| Modality | Small molecule |
| Therapeutic area | Contraception |
| Phase | FDA-approved |
Mechanism of action
Medroxyprogesterone acetate (MPA) is a synthetic progestin that acts on the hypothalamic-pituitary-ovarian axis to inhibit the LH surge required for ovulation. It also alters the endometrium and increases cervical mucus viscosity, creating multiple barriers to conception. The injection provides sustained contraceptive effect for approximately 12 weeks per dose.
Approved indications
- Contraception in women of reproductive age
Common side effects
- Irregular bleeding or amenorrhea
- Weight gain
- Headache
- Breast tenderness
- Abdominal pain or bloating
- Delayed return to fertility
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Depo-Provera Contraceptive Injection - DP150CI CI brief — competitive landscape report
- Depo-Provera Contraceptive Injection - DP150CI updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Depo-Provera Contraceptive Injection - DP150CI
What is Depo-Provera Contraceptive Injection - DP150CI?
How does Depo-Provera Contraceptive Injection - DP150CI work?
What is Depo-Provera Contraceptive Injection - DP150CI used for?
Who makes Depo-Provera Contraceptive Injection - DP150CI?
What drug class is Depo-Provera Contraceptive Injection - DP150CI in?
What development phase is Depo-Provera Contraceptive Injection - DP150CI in?
What are the side effects of Depo-Provera Contraceptive Injection - DP150CI?
What does Depo-Provera Contraceptive Injection - DP150CI target?
Related
- Drug class: All Progestin contraceptive drugs
- Target: All drugs targeting Progesterone receptor
- Manufacturer: Pfizer — full pipeline
- Therapeutic area: All drugs in Contraception
- Indication: Drugs for Contraception in women of reproductive age
- Compare: Depo-Provera Contraceptive Injection - DP150CI vs similar drugs
- Pricing: Depo-Provera Contraceptive Injection - DP150CI cost, discount & access